ID   PAR14_HUMAN             Reviewed;        1801 AA.
AC   Q460N5; B4E2H0; Q460N4; Q8J027; Q9H9X9; Q9NV60; Q9ULF2;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 3.
DT   10-MAY-2017, entry version 111.
DE   RecName: Full=Poly [ADP-ribose] polymerase 14;
DE            Short=PARP-14;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 8;
DE            Short=ARTD8;
DE   AltName: Full=B aggressive lymphoma protein 2;
GN   Name=PARP14; Synonyms=BAL2, KIAA1268;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RA   Guo J.H., Yu L.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1560 (ISOFORMS 1 AND 5),
RP   AND NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1380-1801 (ISOFORMS
RP   1/3/6).
RC   TISSUE=Ovarian carcinoma, Teratocarcinoma, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-266 (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=16344560; DOI=10.1101/gr.4039406;
RA   Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T.,
RA   Yamashita R., Yamamoto J., Sekine M., Tsuritani K., Wakaguri H.,
RA   Ishii S., Sugiyama T., Saito K., Isono Y., Irie R., Kushida N.,
RA   Yoneyama T., Otsuka R., Kanda K., Yokoi T., Kondo H., Wagatsuma M.,
RA   Murakawa K., Ishida S., Ishibashi T., Takahashi-Fujii A., Tanase T.,
RA   Nagai K., Kikuchi H., Nakai K., Isogai T., Sugano S.;
RT   "Diversification of transcriptional modulation: large-scale
RT   identification and characterization of putative alternative promoters
RT   of human genes.";
RL   Genome Res. 16:55-65(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 160-1801 (ISOFORM 4), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 160-1801 (ISOFORM 1), ALTERNATIVE SPLICING, AND
RP   FUNCTION.
RX   PubMed=16061477; DOI=10.1074/jbc.M505408200;
RA   Aguiar R.C.T., Takeyama K., He C., Kreinbrink K., Shipp M.A.;
RT   "B-aggressive lymphoma family proteins have unique domains that
RT   modulate transcription and exhibit poly(ADP-ribose) polymerase
RT   activity.";
RL   J. Biol. Chem. 280:33756-33765(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 658-1801 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33 AND SER-1411, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1403, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1611-1801.
RX   PubMed=22823910; DOI=10.1021/jm300746d;
RA   Andersson C.D., Karlberg T., Ekblad T., Lindgren A.E., Thorsell A.G.,
RA   Spjut S., Uciechowska U., Niemiec M.S., Wittung-Stafshede P.,
RA   Weigelt J., Elofsson M., Schuler H., Linusson A.;
RT   "Discovery of ligands for ADP-ribosyltransferases via docking-based
RT   virtual screening.";
RL   J. Med. Chem. 55:7706-7718(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 1611-1801.
RX   PubMed=22343925; DOI=10.1038/nbt.2121;
RA   Wahlberg E., Karlberg T., Kouznetsova E., Markova N., Macchiarulo A.,
RA   Thorsell A.G., Pol E., Frostell A., Ekblad T., Oncu D., Kull B.,
RA   Robertson G.M., Pellicciari R., Schuler H., Weigelt J.;
RT   "Family-wide chemical profiling and structural analysis of PARP and
RT   tankyrase inhibitors.";
RL   Nat. Biotechnol. 30:283-288(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF 784-1196 AND 1208-1388 IN
RP   COMPLEX WITH SUBSTRATE, INTERACTION WITH PARP10, AND MUTAGENESIS OF
RP   GLY-1055.
RX   PubMed=23473667; DOI=10.1016/j.str.2012.12.019;
RA   Forst A.H., Karlberg T., Herzog N., Thorsell A.G., Gross A.,
RA   Feijs K.L., Verheugd P., Kursula P., Nijmeijer B., Kremmer E.,
RA   Kleine H., Ladurner A.G., Schuler H., Luscher B.;
RT   "Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8
RT   macrodomains.";
RL   Structure 21:462-475(2013).
CC   -!- FUNCTION: Enhances STAT6-dependent transcription (By similarity).
CC       Has ADP-ribosyltransferase activity. {ECO:0000250,
CC       ECO:0000269|PubMed:16061477}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397}.
CC   -!- SUBUNIT: Interacts with STAT6 (By similarity). Interacts with
CC       PARP10 (PubMed:23473667). {ECO:0000250|UniProtKB:Q2EMV9,
CC       ECO:0000269|PubMed:23473667}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=In steady state
CC       cells the protein is mostly nuclear. A minor proportion is
CC       detected in the cytoplasm (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=6;
CC         IsoId=Q460N5-6; Sequence=Displayed;
CC       Name=1; Synonyms=BAL2B;
CC         IsoId=Q460N5-1; Sequence=VSP_040876;
CC       Name=3; Synonyms=BAL2A;
CC         IsoId=Q460N5-3; Sequence=VSP_020014;
CC       Name=4;
CC         IsoId=Q460N5-4; Sequence=VSP_020018, VSP_020019;
CC       Name=5;
CC         IsoId=Q460N5-5; Sequence=VSP_020013, VSP_020017;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY64449.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAY64450.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14089.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=DB237115; Type=Frameshift; Positions=48; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY134858; AAN08627.1; -; mRNA.
DR   EMBL; AC048348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK001770; BAA91897.1; -; mRNA.
DR   EMBL; AK022542; BAB14089.1; ALT_INIT; mRNA.
DR   EMBL; AK304269; BAG65132.1; -; mRNA.
DR   EMBL; DB237115; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; DQ063584; AAY64449.1; ALT_INIT; mRNA.
DR   EMBL; DQ063585; AAY64450.1; ALT_INIT; mRNA.
DR   EMBL; AB033094; BAA86582.1; -; mRNA.
DR   CCDS; CCDS46894.1; -. [Q460N5-6]
DR   RefSeq; NP_060024.2; NM_017554.2. [Q460N5-6]
DR   UniGene; Hs.518203; -.
DR   PDB; 3GOY; X-ray; 2.80 A; A/B/C/D=1611-1801.
DR   PDB; 3Q6Z; X-ray; 2.23 A; A=789-979.
DR   PDB; 3Q71; X-ray; 2.20 A; A=999-1196.
DR   PDB; 3SE2; X-ray; 2.30 A; A/B/C/D=1611-1801.
DR   PDB; 3SMI; X-ray; 2.40 A; A/B=1611-1801.
DR   PDB; 3SMJ; X-ray; 1.50 A; A/B=1611-1801.
DR   PDB; 3VFQ; X-ray; 2.80 A; A=784-1196.
DR   PDB; 4ABK; X-ray; 1.60 A; A=1208-1388.
DR   PDB; 4ABL; X-ray; 1.15 A; A=1208-1388.
DR   PDB; 4D86; X-ray; 2.00 A; A=784-1196.
DR   PDB; 4F1L; X-ray; 1.90 A; A/B/C/D=1611-1801.
DR   PDB; 4F1Q; X-ray; 2.80 A; A/B=1611-1801.
DR   PDB; 4PY4; X-ray; 2.76 A; A/B=1613-1801.
DR   PDB; 5LXP; X-ray; 2.07 A; A/B=1611-1801.
DR   PDB; 5LYH; X-ray; 2.17 A; A/B=1611-1801.
DR   PDBsum; 3GOY; -.
DR   PDBsum; 3Q6Z; -.
DR   PDBsum; 3Q71; -.
DR   PDBsum; 3SE2; -.
DR   PDBsum; 3SMI; -.
DR   PDBsum; 3SMJ; -.
DR   PDBsum; 3VFQ; -.
DR   PDBsum; 4ABK; -.
DR   PDBsum; 4ABL; -.
DR   PDBsum; 4D86; -.
DR   PDBsum; 4F1L; -.
DR   PDBsum; 4F1Q; -.
DR   PDBsum; 4PY4; -.
DR   PDBsum; 5LXP; -.
DR   PDBsum; 5LYH; -.
DR   ProteinModelPortal; Q460N5; -.
DR   SMR; Q460N5; -.
DR   BioGrid; 120082; 13.
DR   DIP; DIP-61130N; -.
DR   STRING; 9606.ENSP00000418194; -.
DR   BindingDB; Q460N5; -.
DR   ChEMBL; CHEMBL2176777; -.
DR   iPTMnet; Q460N5; -.
DR   PhosphoSitePlus; Q460N5; -.
DR   BioMuta; PARP14; -.
DR   DMDM; 327478567; -.
DR   EPD; Q460N5; -.
DR   MaxQB; Q460N5; -.
DR   PaxDb; Q460N5; -.
DR   PeptideAtlas; Q460N5; -.
DR   PRIDE; Q460N5; -.
DR   Ensembl; ENST00000474629; ENSP00000418194; ENSG00000173193. [Q460N5-6]
DR   GeneID; 54625; -.
DR   KEGG; hsa:54625; -.
DR   UCSC; uc003efq.5; human. [Q460N5-6]
DR   CTD; 54625; -.
DR   DisGeNET; 54625; -.
DR   GeneCards; PARP14; -.
DR   H-InvDB; HIX0019605; -.
DR   HGNC; HGNC:29232; PARP14.
DR   HPA; HPA008846; -.
DR   HPA; HPA012063; -.
DR   MIM; 610028; gene.
DR   neXtProt; NX_Q460N5; -.
DR   OpenTargets; ENSG00000173193; -.
DR   PharmGKB; PA134861585; -.
DR   eggNOG; KOG2633; Eukaryota.
DR   eggNOG; COG2110; LUCA.
DR   GeneTree; ENSGT00760000119084; -.
DR   HOVERGEN; HBG082105; -.
DR   InParanoid; Q460N5; -.
DR   KO; K15261; -.
DR   OMA; RRCHCEL; -.
DR   OrthoDB; EOG091G00EB; -.
DR   PhylomeDB; Q460N5; -.
DR   TreeFam; TF328965; -.
DR   BRENDA; 2.4.2.30; 2681.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   ChiTaRS; PARP14; human.
DR   EvolutionaryTrace; Q460N5; -.
DR   GenomeRNAi; 54625; -.
DR   PRO; PR:Q460N5; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000173193; -.
DR   CleanEx; HS_PARP14; -.
DR   ExpressionAtlas; Q460N5; baseline and differential.
DR   Genevisible; Q460N5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd12543; RRM2_PAR14; 1.
DR   Gene3D; 3.30.1370.10; -; 1.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR034517; PAR14_RRM2.
DR   InterPro; IPR034399; PARP14.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR004170; WWE-dom.
DR   PANTHER; PTHR14453:SF71; PTHR14453:SF71; 1.
DR   Pfam; PF01661; Macro; 3.
DR   Pfam; PF00644; PARP; 1.
DR   SMART; SM00506; A1pp; 3.
DR   PROSITE; PS51154; MACRO; 3.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS50918; WWE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Glycosyltransferase; NAD; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Transferase.
FT   CHAIN         1   1801       Poly [ADP-ribose] polymerase 14.
FT                                /FTId=PRO_0000247589.
FT   DOMAIN      791    978       Macro 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN     1003   1190       Macro 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN     1216   1387       Macro 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN     1523   1601       WWE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00248}.
FT   DOMAIN     1605   1801       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   REGION      922    926       Substrate 1 binding.
FT                                {ECO:0000244|PDB:3Q6Z,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1023   1024       Substrate 2 binding.
FT                                {ECO:0000244|PDB:3Q71,
FT                                ECO:0000244|PDB:3VFQ,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1046   1049       Substrate 2 binding.
FT                                {ECO:0000244|PDB:3Q71,
FT                                ECO:0000244|PDB:3VFQ,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1133   1137       Substrate 2 binding.
FT                                {ECO:0000244|PDB:3Q71,
FT                                ECO:0000244|PDB:3VFQ,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1175   1178       Substrate 2 binding.
FT                                {ECO:0000244|PDB:3Q71,
FT                                ECO:0000244|PDB:3VFQ,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1235   1236       Substrate 3 binding.
FT                                {ECO:0000244|PDB:4ABK,
FT                                ECO:0000269|PubMed:23473667}.
FT   REGION     1332   1336       Substrate 3 binding.
FT                                {ECO:0000244|PDB:3Q71,
FT                                ECO:0000244|PDB:3VFQ,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     824    824       Substrate 1. {ECO:0000244|PDB:3Q6Z,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     833    833       Substrate 1; via amide nitrogen.
FT                                {ECO:0000244|PDB:3Q6Z,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING     961    961       Substrate 1. {ECO:0000244|PDB:3Q6Z,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING    1034   1034       Substrate 2. {ECO:0000244|PDB:4ABK,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING    1247   1247       Substrate 3. {ECO:0000244|PDB:4ABK,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING    1258   1258       Substrate 3; via amide nitrogen.
FT                                {ECO:0000244|PDB:4ABK,
FT                                ECO:0000269|PubMed:23473667}.
FT   BINDING    1371   1371       Substrate 3. {ECO:0000244|PDB:4ABK,
FT                                ECO:0000269|PubMed:23473667}.
FT   MOD_RES      33     33       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1403   1403       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1411   1411       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1   1004       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020013.
FT   VAR_SEQ       1    283       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_020014.
FT   VAR_SEQ     119    199       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:16061477,
FT                                ECO:0000303|PubMed:16344560}.
FT                                /FTId=VSP_040876.
FT   VAR_SEQ    1005   1013       KGSLVSPGG -> MYLRRLLRP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020017.
FT   VAR_SEQ    1648   1680       IERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQL -> VSLL
FT                                LECSFWMVEISSVMVLYKIHFHSLPITFF (in isoform
FT                                4). {ECO:0000303|PubMed:10574462,
FT                                ECO:0000303|PubMed:16061477}.
FT                                /FTId=VSP_020018.
FT   VAR_SEQ    1681   1801       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10574462,
FT                                ECO:0000303|PubMed:16061477}.
FT                                /FTId=VSP_020019.
FT   MUTAGEN    1055   1055       G->E: Abolishes interaction with PARP10.
FT                                {ECO:0000269|PubMed:23473667}.
FT   CONFLICT     59     59       Y -> C (in Ref. 4; DB237115).
FT                                {ECO:0000305}.
FT   CONFLICT    597    597       N -> D (in Ref. 3; BAG65132).
FT                                {ECO:0000305}.
FT   CONFLICT   1239   1239       E -> G (in Ref. 3; BAA91897).
FT                                {ECO:0000305}.
FT   CONFLICT   1499   1499       G -> A (in Ref. 1; AAN08627).
FT                                {ECO:0000305}.
FT   CONFLICT   1521   1521       A -> G (in Ref. 1; AAN08627).
FT                                {ECO:0000305}.
FT   STRAND      792    799       {ECO:0000244|PDB:4D86}.
FT   STRAND      802    808       {ECO:0000244|PDB:4D86}.
FT   STRAND      815    823       {ECO:0000244|PDB:4D86}.
FT   HELIX       832    841       {ECO:0000244|PDB:4D86}.
FT   HELIX       844    856       {ECO:0000244|PDB:4D86}.
FT   STRAND      861    868       {ECO:0000244|PDB:4D86}.
FT   STRAND      872    881       {ECO:0000244|PDB:4D86}.
FT   HELIX       887    889       {ECO:0000244|PDB:4D86}.
FT   HELIX       890    910       {ECO:0000244|PDB:4D86}.
FT   STRAND      914    918       {ECO:0000244|PDB:4D86}.
FT   TURN        921    926       {ECO:0000244|PDB:3VFQ}.
FT   HELIX       930    947       {ECO:0000244|PDB:4D86}.
FT   STRAND      956    963       {ECO:0000244|PDB:4D86}.
FT   HELIX       964    977       {ECO:0000244|PDB:4D86}.
FT   STRAND     1007   1009       {ECO:0000244|PDB:4D86}.
FT   STRAND     1015   1019       {ECO:0000244|PDB:4D86}.
FT   HELIX      1023   1025       {ECO:0000244|PDB:4D86}.
FT   STRAND     1028   1034       {ECO:0000244|PDB:4D86}.
FT   STRAND     1041   1044       {ECO:0000244|PDB:4D86}.
FT   HELIX      1045   1054       {ECO:0000244|PDB:4D86}.
FT   HELIX      1057   1066       {ECO:0000244|PDB:4D86}.
FT   STRAND     1076   1080       {ECO:0000244|PDB:4D86}.
FT   STRAND     1084   1092       {ECO:0000244|PDB:4D86}.
FT   HELIX      1098   1100       {ECO:0000244|PDB:4D86}.
FT   HELIX      1102   1121       {ECO:0000244|PDB:4D86}.
FT   STRAND     1126   1130       {ECO:0000244|PDB:4D86}.
FT   HELIX      1141   1158       {ECO:0000244|PDB:4D86}.
FT   STRAND     1166   1170       {ECO:0000244|PDB:4D86}.
FT   HELIX      1176   1189       {ECO:0000244|PDB:4D86}.
FT   STRAND     1213   1216       {ECO:0000244|PDB:4ABK}.
FT   STRAND     1220   1224       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1227   1234       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1236   1238       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1242   1248       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1258   1266       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1268   1280       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1284   1289       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1293   1302       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1307   1320       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1325   1328       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1340   1356       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1365   1371       {ECO:0000244|PDB:4ABL}.
FT   HELIX      1373   1386       {ECO:0000244|PDB:4ABL}.
FT   STRAND     1617   1621       {ECO:0000244|PDB:3SMJ}.
FT   HELIX      1629   1640       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1643   1652       {ECO:0000244|PDB:3SMJ}.
FT   HELIX      1654   1670       {ECO:0000244|PDB:3SMJ}.
FT   TURN       1671   1673       {ECO:0000244|PDB:3SE2}.
FT   STRAND     1677   1684       {ECO:0000244|PDB:3SMJ}.
FT   HELIX      1686   1688       {ECO:0000244|PDB:3SMJ}.
FT   HELIX      1689   1695       {ECO:0000244|PDB:3SMJ}.
FT   TURN       1699   1701       {ECO:0000244|PDB:3SMI}.
FT   HELIX      1704   1706       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1707   1709       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1713   1718       {ECO:0000244|PDB:3SMJ}.
FT   HELIX      1719   1722       {ECO:0000244|PDB:3SMJ}.
FT   TURN       1725   1727       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1736   1744       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1747   1750       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1763   1765       {ECO:0000244|PDB:5LYH}.
FT   STRAND     1771   1775       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1777   1779       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1781   1785       {ECO:0000244|PDB:3SMJ}.
FT   STRAND     1791   1800       {ECO:0000244|PDB:3SMJ}.
SQ   SEQUENCE   1801 AA;  202800 MW;  27B027DFC7E773BD CRC64;
     MAVPGSFPLL VEGSWGPDPP KNLNTKLQMY FQSPKRSGGG ECEVRQDPRS PSRFLVFFYP
     EDVRQKVLER KNHELVWQGK GTFKLTVQLP ATPDEIDHVF EEELLTKESK TKEDVKEPDV
     SEELDTKLPL DGGLDKMEDI PEECENISSL VAFENLKANV TDIMLILLVE NISGLSNDDF
     QVEIIRDFDV AVVTFQKHID TIRFVDDCTK HHSIKQLQLS PRLLEVTNTI RVENLPPGAD
     DYSLKLFFEN PYNGGGRVAN VEYFPEESSA LIEFFDRKVL DTIMATKLDF NKMPLSVFPY
     YASLGTALYG KEKPLIKLPA PFEESLDLPL WKFLQKKNHL IEEINDEMRR CHCELTWSQL
     SGKVTIRPAA TLVNEGRPRI KTWQADTSTT LSSIRSKYKV NPIKVDPTMW DTIKNDVKDD
     RILIEFDTLK EMVILAGKSE DVQSIEVQVR ELIESTTQKI KREEQSLKEK MIISPGRYFL
     LCHSSLLDHL LTECPEIEIC YDRVTQHLCL KGPSADVYKA KCEIQEKVYT MAQKNIQVSP
     EIFQFLQQVN WKEFSKCLFI AQKILALYEL EGTTVLLTSC SSEALLEAEK QMLSALNYKR
     IEVENKEVLH GKKWKGLTHN LLKKQNSSPN TVIINELTSE TTAEVIITGC VKEVNETYKL
     LFNFVEQNMK IERLVEVKPS LVIDYLKTEK KLFWPKIKKV NVQVSFNPEN KQKGILLTGS
     KTEVLKAVDI VKQVWDSVCV KSVHTDKPGA KQFFQDKARF YQSEIKRLFG CYIELQENEV
     MKEGGSPAGQ KCFSRTVLAP GVVLIVQQGD LARLPVDVVV NASNEDLKHY GGLAAALSKA
     AGPELQADCD QIVKREGRLL PGNATISKAG KLPYHHVIHA VGPRWSGYEA PRCVYLLRRA
     VQLSLCLAEK YKYRSIAIPA ISSGVFGFPL GRCVETIVSA IKENFQFKKD GHCLKEIYLV
     DVSEKTVEAF AEAVKTVFKA TLPDTAAPPG LPPAAAGPGK TSWEKGSLVS PGGLQMLLVK
     EGVQNAKTDV VVNSVPLDLV LSRGPLSKSL LEKAGPELQE ELDTVGQGVA VSMGTVLKTS
     SWNLDCRYVL HVVAPEWRNG STSSLKIMED IIRECMEITE SLSLKSIAFP AIGTGNLGFP
     KNIFAELIIS EVFKFSSKNQ LKTLQEVHFL LHPSDHENIQ AFSDEFARRA NGNLVSDKIP
     KAKDTQGFYG TVSSPDSGVY EMKIGSIIFQ VASGDITKEE ADVIVNSTSN SFNLKAGVSK
     AILECAGQNV ERECSQQAQQ RKNDYIITGG GFLRCKNIIH VIGGNDVKSS VSSVLQECEK
     KNYSSICLPA IGTGNAKQHP DKVAEAIIDA IEDFVQKGSA QSVKKVKVVI FLPQVLDVFY
     ANMKKREGTQ LSSQQSVMSK LASFLGFSKQ SPQKKNHLVL EKKTESATFR VCGENVTCVE
     YAISWLQDLI EKEQCPYTSE DECIKDFDEK EYQELNELQK KLNINISLDH KRPLIKVLGI
     SRDVMQARDE IEAMIKRVRL AKEQESRADC ISEFIEWQYN DNNTSHCFNK MTNLKLEDAR
     REKKKTVDVK INHRHYTVNL NTYTATDTKG HSLSVQRLTK SKVDIPAHWS DMKQQNFCVV
     ELLPSDPEYN TVASKFNQTC SHFRIEKIER IQNPDLWNSY QAKKKTMDAK NGQTMNEKQL
     FHGTDAGSVP HVNRNGFNRS YAGKNAVAYG KGTYFAVNAN YSANDTYSRP DANGRKHVYY
     VRVLTGIYTH GNHSLIVPPS KNPQNPTDLY DTVTDNVHHP SLFVAFYDYQ AYPEYLITFR
     K
//
